Apr. 2, 2019
By Leonardo Gottems, reporter for AgroPages
Bayer has introduced its new industrial biological soybean inoculant in Brazil, the CTS 500. The product has already been tested by Monsanto, through the company BioAg long-life inoculants, in its Industrial Seed Treatment (TSI) program beginning last year.
According to Bayer, the CTS 500 is a solution platform that brings together biological inoculants of selected bacteria with high efficiency and nitrogen fixation, which provides the largest possible number of nodules in the main root. The new formulation of the product guarantees 60 days of pre-treatment in soybean seeds, with a higher concentration of bacteria associated with the survival of the market seed. In addition, the product is compatible with the main agrochemicals of the market, which facilitates and optimizes its application and reduces operational costs on the farm.
The manufacturer guarantees that the biological inoculant CTS 500 will be available for the 2019/2020 harvest. Bayer has displayed this solution at agricultural fairs in Brazil.
"Bayer offers farmers biological solutions that can help them in the field and benefit the crop in a number of ways, including improving nitrogen availability and absorption, promoting crop growth, and increasing productivity potential, always using technology of high-efficiency bacteria," the company noted.
According to the Commercial Director of Bayer in Brazil, Márcio Santos, the CTS 500 joins the company's other biological solutions, such as the microbial fungicide Serenade (Bacillus subtilis lineage QST 713). The executive added that products of this line constitute an "important part of the market" that the company is offering Brazilian rural producers.